103880-70-2

Upstream product

• 140135-14-4 4-((S)-6-Benzyloxycarbonylamino-2-tert-butoxycarbonylamino-hexanoylamino)-benzoic acid ethyl ester 
• 126583-16-2 Boc-Lys(Z)-OCOOEt 
• 27687-12-3 (1r,4r)-4-({[(benzyloxy)carbonyl]amino}methyl)cyclohexane-1-carboxylic acid 
• 2389-45-9 Boc-Lys(Z)-OH 
• 27687-13-4 trans-4-(N-carbobenzyloxy)aminomethyl-1-cyclohexane carbonyl chloride 
• 140135-18-8 4-((S)-6-Benzyloxycarbonylamino-2-{[4-(benzyloxycarbonylamino-methyl)-cyclohexanecarbonyl]-amino}-hexanoylamino)-benzoic acid ethyl ester 

Relevant academic research and scientific papers

Development of selective inhibitors against plasma kallikrein

Specific plasma kallikrein inhibitors were designed and synthesized and their structure-activity relationship was studied. trans-4-Aminomethylcyclohexanecarbonyl(Tra)-lysyl-4-ethoxycarbonylanili de inhibited plasma kallikrein and plasmin with 1C50/s